Last reviewed · How we verify

NCT06868862: COMEFIT

Acute Effects of Isoenergetic HIIE Vs. MICE on Key Parameters of Fat Mass Loss in Young Females with Overweight or Obesity

Recruiting now NA Last updated 11 March 2025
What this trial tests

NA trial testing Exercise in Overweight and Obese Adults in 15 participants. Currently enrolling.

Timeline
1 February 2025
Primary endpoint
30 December 2025
30 December 2025

Quick facts

Lead sponsorLaboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designcrossover
Maskingsingle
Primary purposeprevention
Enrollment15
Start date1 February 2025
Primary completion30 December 2025
Estimated completion30 December 2025
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques

Who can join

Adults 20 to 45, female only, with Overweight and Obese Adults or High Intensity Interval Exercise (HIIE). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Overweight and obesity, particularly increased total and/or abdominal fat mass (FM), are strongly linked to the development of cardiovascular diseases. Managing obesity effectively requires lifestyle and dietary modifications, including increased physical activity. Among the various exercise strategies, Moderate-Intensity Continuous Training (MICT) and High-Intensity Interval Training (HIIT) are widely recommended for reducing FM. Compared to MICT, HIIT is a time-efficient approach, often perceived as more enjoyable, and has been shown to promote greater total and abdominal fat loss in a shorter period. However, the precise mechanisms underlying this enhanced fat loss remain unclear. This study aims to compare the acute effects of two isoenergetic exercise sessions - MICE (Moderate-Intensity Continuous Exercise) and HIIE (High-Intensity Interval Exercise) - on key physiological responses involved in fat mass loss. Specifically, we will assess plasma catecholamine levels during exercise and recovery, as well as oxygen consumption, substrate oxidation, and appetite over the 2-hour post-exercise period in young females with overweight or obesity. By elucidating the role of catecholaminergic stimulation as a potential regulator of fat mass loss, this research could provide valuable insights for optimizing exercise strategies in weight management and metabolic health.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Overweight and Obese Adults

Currently open trials in the same condition.

Other Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06868862.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing